SK281949B6 - Derivát benzamidu, farmaceutický prostriedok, ktorý ho obsahuje, a použitie - Google Patents
Derivát benzamidu, farmaceutický prostriedok, ktorý ho obsahuje, a použitie Download PDFInfo
- Publication number
- SK281949B6 SK281949B6 SK1307-96A SK130796A SK281949B6 SK 281949 B6 SK281949 B6 SK 281949B6 SK 130796 A SK130796 A SK 130796A SK 281949 B6 SK281949 B6 SK 281949B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- derivative
- pharmaceutical composition
- benzamide derivative
- benzamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/227,033 US5387598A (en) | 1994-04-13 | 1994-04-13 | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
US08/301,407 US5578621A (en) | 1994-09-08 | 1994-09-08 | Benzamide derivatives |
US38385595A | 1995-02-06 | 1995-02-06 | |
PCT/EP1995/001334 WO1995028393A1 (fr) | 1994-04-13 | 1995-04-11 | Derive de benzamide, compositions le contenant et son utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
SK130796A3 SK130796A3 (en) | 1997-06-04 |
SK281949B6 true SK281949B6 (sk) | 2001-09-11 |
Family
ID=27397680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1307-96A SK281949B6 (sk) | 1994-04-13 | 1995-04-11 | Derivát benzamidu, farmaceutický prostriedok, ktorý ho obsahuje, a použitie |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0755386B1 (fr) |
JP (1) | JP3224395B2 (fr) |
KR (2) | KR100348440B1 (fr) |
CN (1) | CN1072654C (fr) |
AP (1) | AP645A (fr) |
AT (1) | ATE218557T1 (fr) |
AU (1) | AU689582B2 (fr) |
BG (1) | BG62932B1 (fr) |
BR (1) | BR9507371A (fr) |
CA (1) | CA2187110C (fr) |
CZ (1) | CZ287002B6 (fr) |
DE (1) | DE69526936T2 (fr) |
DK (1) | DK0755386T3 (fr) |
ES (1) | ES2161201T3 (fr) |
FI (1) | FI120258B (fr) |
HU (1) | HUT77404A (fr) |
NZ (1) | NZ284800A (fr) |
OA (1) | OA10463A (fr) |
PL (1) | PL186504B1 (fr) |
PT (1) | PT755386E (fr) |
RU (1) | RU2140915C1 (fr) |
SI (1) | SI0755386T1 (fr) |
SK (1) | SK281949B6 (fr) |
WO (1) | WO1995028393A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968961A (en) | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
US5856348A (en) * | 1994-09-08 | 1999-01-05 | Romark Laboratories, L.C. | Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide |
CA2467321A1 (fr) | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci |
WO2006022944A2 (fr) | 2004-07-21 | 2006-03-02 | Dana-Farber Cancer Institute, Inc. | Vecteurs lentiviraux et utilisations associees |
UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
ZA200806310B (en) | 2006-01-09 | 2009-12-30 | Romark Lab Lc | Viral hepatitis treatment |
PT2178852E (pt) | 2007-08-03 | 2015-11-12 | Romark Lab Lc | Compostos tiazolida substituídos com alquilsulfonilo |
SG10201402281WA (en) | 2009-05-12 | 2014-07-30 | Romark Lab Lc | Haloalkyl heteroaryl benzamide compounds |
BRPI1014322A2 (pt) * | 2009-06-26 | 2015-08-25 | Romark Lab Lc | Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica. |
AU2010310892B2 (en) | 2009-10-22 | 2015-07-02 | Thomas Julius Borody | Novel parasite therapy |
CN104094927B (zh) * | 2013-04-02 | 2016-06-01 | 兴邦(武汉)生物科技有限公司 | 一种处理植物的助剂组合物 |
TW201630606A (zh) * | 2015-01-21 | 2016-09-01 | 諾華公司 | 包含局部藥物之蓋崙(galenic)調配物 |
US11612567B2 (en) | 2018-02-02 | 2023-03-28 | Ripple Therapeutics Corporation | Ocular inserts comprising a covalently linked steroid dimer |
CA3176134A1 (fr) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Compositions heterodimeres et methodes pour le traitement de troubles oculaires |
CA3219500A1 (fr) * | 2021-05-28 | 2022-12-01 | Theodore HENDERSON | Traitement utilisant un compose antiviral et du nitazoxanide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1306603A (fr) * | 1958-08-14 | 1962-10-19 | Innothera Lab Sa | Dérivés thiazoliques et leur procédé de préparation |
FR716M (fr) * | 1960-08-05 | 1961-08-07 | ||
GB1437800A (en) * | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
FR2435905A1 (fr) * | 1978-09-13 | 1980-04-11 | Anvar | Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole |
US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
US4447414A (en) * | 1982-12-21 | 1984-05-08 | Cutter Laboratories, Inc. | Carnivore anthelmintics |
-
1995
- 1995-04-11 DE DE69526936T patent/DE69526936T2/de not_active Revoked
- 1995-04-11 SI SI9530607T patent/SI0755386T1/xx unknown
- 1995-04-11 KR KR1019960705785A patent/KR100348440B1/ko not_active IP Right Cessation
- 1995-04-11 EP EP95917310A patent/EP0755386B1/fr not_active Revoked
- 1995-04-11 JP JP52669395A patent/JP3224395B2/ja not_active Expired - Lifetime
- 1995-04-11 PT PT95917310T patent/PT755386E/pt unknown
- 1995-04-11 SK SK1307-96A patent/SK281949B6/sk not_active IP Right Cessation
- 1995-04-11 AT AT95917310T patent/ATE218557T1/de not_active IP Right Cessation
- 1995-04-11 NZ NZ284800A patent/NZ284800A/en not_active IP Right Cessation
- 1995-04-11 DK DK95917310T patent/DK0755386T3/da active
- 1995-04-11 BR BR9507371A patent/BR9507371A/pt not_active IP Right Cessation
- 1995-04-11 CN CN95192524A patent/CN1072654C/zh not_active Expired - Fee Related
- 1995-04-11 PL PL95316757A patent/PL186504B1/pl not_active IP Right Cessation
- 1995-04-11 CA CA002187110A patent/CA2187110C/fr not_active Expired - Lifetime
- 1995-04-11 ES ES95917310T patent/ES2161201T3/es not_active Expired - Lifetime
- 1995-04-11 RU RU96119364A patent/RU2140915C1/ru not_active IP Right Cessation
- 1995-04-11 HU HU9602798A patent/HUT77404A/hu unknown
- 1995-04-11 CZ CZ19962959A patent/CZ287002B6/cs not_active IP Right Cessation
- 1995-04-11 KR KR10-2000-7003874A patent/KR100373081B1/ko not_active IP Right Cessation
- 1995-04-11 AP APAP/P/1996/000866A patent/AP645A/en active
- 1995-04-11 WO PCT/EP1995/001334 patent/WO1995028393A1/fr not_active Application Discontinuation
- 1995-04-11 AU AU23440/95A patent/AU689582B2/en not_active Ceased
-
1996
- 1996-10-03 BG BG100884A patent/BG62932B1/bg unknown
- 1996-10-04 OA OA60900A patent/OA10463A/en unknown
- 1996-10-08 FI FI964031A patent/FI120258B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK281949B6 (sk) | Derivát benzamidu, farmaceutický prostriedok, ktorý ho obsahuje, a použitie | |
MXPA96004483A (en) | Derivatives of benzamide, compositions that contain such derivative and use of the mis | |
DE69828196T2 (de) | Verfahren zur vorbeugung und behandlung bakterieller infektionen unter verwendung von celluloseacetatphthalat- oder hydroxyproppylmethylcelluloseträgerstoffen | |
AU737038B2 (en) | Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof | |
SK131899A3 (en) | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases | |
DK169437B1 (da) | Chloreret uracilnucleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutiske præparater indeholdende forbindelsen samt fremgangsmåde ti l fremstilling af forbindelsen | |
Lampis et al. | Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins | |
HU187324B (en) | Process for the preparation of esters of hydroxy-alkyl-purins | |
EP1222921B1 (fr) | Compositions pharmaceutiques contenant du tizoxanide et/ou du nitazoxanide | |
CA2873390C (fr) | Composes complexes de germanium, procedes de leur production et medicaments | |
AU2734095A (en) | A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof | |
EP3235511A1 (fr) | Composées des sulphonamides destinées au traitement des maladies associées avec hhv-8 | |
MXPA00010855A (es) | Uso de derivados de benzamida como agentes parasitarios, antibacterianos, antivirales y antifungicos | |
RO118293B1 (ro) | Derivat de benzamida, compozitii continand acest derivat si utilizarea acestuia | |
KR101501211B1 (ko) | 액틴 관련 단백질 2/3 복합체 저해제를 유효성분으로 포함하는 수컷의 수태능력 억제용 약학적 조성물 | |
WO2002020014A1 (fr) | Inhibiteurs non competitifs de l'helicase-primase | |
KR100718030B1 (ko) | 변형성 관절증 치료제 | |
EP0082667A1 (fr) | Compositions pharmaceutiques | |
JPS6136728B2 (fr) | ||
CZ283197A3 (cs) | Použití pencicloviru pro léčení herpes-viru-8 u lidí a farmaceutický prostředek | |
JPS61176527A (ja) | 抗ウイルス感染剤 | |
DK160833B (da) | Heterocycliske pyrano-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne forbindelser | |
KR20150003125A (ko) | 액틴 관련 단백질 2/3 복합체 저해제를 유효성분으로 포함하는 수컷의 수태능력 억제용 약학적 조성물 | |
JPH05112449A (ja) | メンフエゴールからなる単純ヘルペスウイルス感染予防治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20120411 |